triplet repeat-primed PCR
Asuragen Fragile X Diagnostic Test Gets FDA Authorization
The firm's AmplideX Fragile X Dx and Carrier Screen Kit is intended to help diagnose fragile X syndrome and assess parental risk of having a child with the syndrome.
Australian Study Highlights Carrier Screening Impacts in Reproductive Context
Carrier screens for cystic fibrosis, fragile X syndrome, and spinal muscular atrophy detected carrier status in one in 20 individuals and led to diagnoses in seven pregnancies.
Asuragen to Develop IVD Kits on Thermo Fisher Scientific's CE Platform
Under the collaboration, Asuragen will develop diagnostic kits for analyzing repeat sequences using Thermo Fisher's 3500 Dx Series Genetic Analyzer CS2 instrument.
ARUP Adapts Triplet Repeat PCR Method for Huntington's Testing, Eliminating Need for Southern Blot
Utah's ARUP Laboratories has replaced its previous approach to PCR-based Huntington's disease testing with a triple repeat primed PCR method developed by ARUP's' Elaine Lyon.
With the approval, Quest can offer the test to physicians in New York as well as in all other US states, as New York is the only state with an independent regulatory review process for lab-developed tests.
May 20, 2010